Definitive Tumor Resection after Myeloablative High Dose Chemotherapy Is a Feasible and Effective Option in the Multimodal Treatment of High-Risk Neuroblastoma: A Single Institution Experience.
J Pediatr Surg
; 55(8): 1655-1659, 2020 Aug.
Article
en En
| MEDLINE
| ID: mdl-31575417
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Neuroblastoma
Tipo de estudio:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
J Pediatr Surg
Año:
2020
Tipo del documento:
Article